Guillaume Piessen - Publications

Affiliations: 
Lille 2 

105 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 von Holzen U, Schmidt S, Hayoz S, Steffen T, Grieder F, Bartsch D, Schnider A, Knoefel WT, Piessen G, Kettelhack C, Marti WR, Schäfer M, Függer R, Königsrainer A, Gloor B, et al. Surgical Outcomes After Neoadjuvant Chemoradiation Followed by Curative Surgery in Patients With Esophageal Cancer: An Intergroup Phase lll Trial of the Swiss Group for Clinical Cancer Research (SAKK 75/08). Annals of Surgery. PMID 33055589 DOI: 10.1097/Sla.0000000000004334  0.382
2020 Baiocchi GL, Giacopuzzi S, Reim D, Piessen G, Costa PMD, Reynolds JV, Meyer HJ, Morgagni P, Gockel I, Santos LL, Jensen LS, Murphy T, D'Ugo D, Rosati R, Fumagalli Romario U, et al. Incidence and Grading of Complications after Gastrectomy for Cancer Using the GASTRODATA Registry: A European Retrospective Observational Study. Annals of Surgery. PMID 32925254 DOI: 10.1097/Sla.0000000000004341  0.358
2020 Doussot A, Vernerey D, Rullier E, H Lefevre J, Meillat H, Cotte E, Piessen G, Tuech JJ, Panis Y, Mege D, Meurisse A, De Bari B, Heyd B, Lakkis Z. Surgical Management and Outcomes of Rectal Cancer with Synchronous Prostate Cancer: A Multicenter Experience from the GRECCAR Group. Annals of Surgical Oncology. PMID 32500342 DOI: 10.1245/S10434-020-08683-4  0.321
2020 Pasquer A, Gronnier C, Piessen G. What are the Particularities of Gastric and Bariatric Surgery in the Cirrhotic Patient. Chirurgia (Bucharest, Romania : 1990). 115: 161-168. PMID 32369720 DOI: 10.21614/Chirurgia.115.2.161  0.338
2020 Bencivenga M, Treppiedi E, Dal Cero M, Torroni L, Verlato G, Iglesias M, Renaud F, Tomezzoli A, Castelli C, Piessen G, Pera M, de Manzoni G. The amount of signet ring cells is significantly associated with tumour stage and survival in gastric poorly cohesive tumours. Journal of Surgical Oncology. PMID 32153051 DOI: 10.1002/Jso.25885  0.346
2020 Cohen R, Pudlarz T, Garcia-Larnicol ML, Vernerey D, Dray X, Clavel L, Jary M, Piessen G, Zaanan A, Aparicio T, Louvet C, Tournigand C, Chibaudel B, Tougeron D, Guimbaud R, et al. [Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment]. Bulletin Du Cancer. PMID 32057467 DOI: 10.1016/J.Bulcan.2019.11.016  0.393
2020 Aparicio T, Henriques J, Manfredi S, Tougeron D, Bouché O, Pezet D, Piessen G, Coriat R, Zaanan A, Legoux JL, Terrebone E, Pocard M, Gornet JM, Lecomte T, Lombard-Bohas C, et al. Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients. International Journal of Cancer. PMID 31912484 DOI: 10.1002/Ijc.32860  0.309
2020 Karoui M, Rullier A, Piessen G, Legoux JL, Barbier E, Chaisemartin CD, Lecaille C, Bouche O, Ammarguellat H, Brunetti F, Prudhomme M, Regimbeau JM, Glehen O, Lievre A, Portier G, et al. Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22). Annals of Surgery. 271: 637-645. PMID 31356278 DOI: 10.1097/Sla.0000000000003454  0.371
2020 Eveno C, Voron T, Piessen G. Correction to: Laparoscopic Hyperthermic Intraperitoneal Chemotherapy for Patients with Gastric Peritoneal Metastases: Limitations and Perspectives. Annals of Surgical Oncology. 26: 889. PMID 31317378 DOI: 10.1245/S10434-019-07632-0  0.339
2020 Karoui M, Gallois C, Piessen G, Legoux J, Barbier E, Chaisemartin CD, Lecaille C, Bouché O, Ammarguellat H, Brunetti F, Prudhomme M, Regimbeau J, Glehen O, Lièvre A, Portier G, et al. Does neoadjuvant FOLFOX chemotherapy improve the oncological prognosis of high-risk stage II and III colon cancers ? Three years’ follow-up results of the Prodige 22 phase II randomized multicenter trial. Journal of Clinical Oncology. 38: 4110-4110. DOI: 10.1200/Jco.2020.38.15_Suppl.4110  0.355
2020 Wilk BVD, Eyck B, Hofstetter W, Ajani J, Piessen G, Castoro C, Alfieri R, Kim J, Kim S, Furlong H, Walsh T, Nieboer D, Wijnhoven B, Lagarde S, Lanschot J. 257 Chemoradiotherapy Followed By Active Surveillance Versus Surgery For Esophageal Cancer: A Systematic Review And Individual Patient Data Meta-Analysis Diseases of the Esophagus. 33. DOI: 10.1093/Dote/Doaa087.50  0.338
2019 Lefèvre JH, Mineur L, Cachanado M, Denost Q, Rouanet P, de Chaisemartin C, Meunier B, Mehrdad J, Cotte E, Desrame J, Karoui M, Benoist S, Kirzin S, Berger A, Panis Y, ... Piessen G, et al. Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years' Follow-up Results of the Greccar-6 Randomized Multicenter Trial. Annals of Surgery. 270: 747-754. PMID 31634178 DOI: 10.1097/Sla.0000000000003530  0.315
2019 Mariette C, Markar S, Dabakuyo-Yonli TS, Meunier B, Pezet D, Collet D, D'Journo XB, Brigand C, Perniceni T, Carrere N, Mabrut JY, Msika S, Peschaud F, Prudhomme M, Bonnetain F, ... Piessen G, et al. Health-related Quality of Life Following Hybrid Minimally Invasive Versus Open Esophagectomy for Patients With Esophageal Cancer, Analysis of a Multicenter, Open-label, Randomized Phase III Controlled Trial: The MIRO Trial. Annals of Surgery. PMID 31404005 DOI: 10.1097/Sla.0000000000003559  0.348
2019 Voron T, Gronnier C, Pasquer A, Thereaux J, Gagniere J, Lebreton G, Meunier B, Collet D, Piessen G, Paye F. Adenocarcinoma of the oesophagogastric junction Siewert II: An oesophageal cancer better cured with total gastrectomy. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. PMID 31350076 DOI: 10.1016/J.Ejso.2019.07.022  0.358
2019 Eveno C, Voron T, Piessen G. Laparoscopic Hyperthermic Intraperitoneal Chemotherapy for Patients with Gastric Peritoneal Metastases: Limitations and Perspectives. Annals of Surgical Oncology. 26: 3009-3010. PMID 31286313 DOI: 10.1245/S10434-019-07603-5  0.35
2019 Bonnot PE, Piessen G, Kepenekian V, Decullier E, Pocard M, Meunier B, Bereder JM, Abboud K, Marchal F, Quenet F, Goere D, Msika S, Arvieux C, Pirro N, Wernert R, et al. Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1801688. PMID 31084544 DOI: 10.1200/Jco.18.01688  0.372
2019 Adenis A, Bennouna J, Etienne PL, Bogart E, Francois E, Galais MP, Ben Abdelghani M, Michel P, Metges JP, Dahan L, Conroy T, Ghiringhelli F, Drouillard A, El Hajbi F, Samalin E, ... ... Piessen G, et al. Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS). European Journal of Cancer (Oxford, England : 1990). 111: 12-20. PMID 30798084 DOI: 10.1016/J.Ejca.2019.01.016  0.373
2019 Eveno C, Adenis A, Bouche O, Le Malicot K, Hautefeuille V, Faroux R, Thirot Bidault A, Egreteau J, Meunier B, Mabro M, Carrere N, Barriere N, Ben Abdelghani M, Mauvais F, Di Fiore F, ... ... Piessen G, et al. Adjuvant chemotherapy versus perioperative chemotherapy (CTx) for resectable gastric signet ring cell (SRC) gastric cancer: A multicenter, randomized phase II study (PRODIGE 19). Journal of Clinical Oncology. 37: 4019-4019. DOI: 10.1200/Jco.2019.37.15_Suppl.4019  0.412
2018 Michot N, Pasco J, Giger-Pabst U, Piessen G, Duron JJ, Salamé E, Grammatico-Guillon L, Ouaïssi M. Long-term hospital mortality due to small bowel obstruction after major colorectal surgery in a national cohort database. International Journal of Colorectal Disease. PMID 30478639 DOI: 10.1007/S00384-018-3200-X  0.324
2018 Canivet C, Gourgou-Bourgade S, Napoléon B, Palazzo L, Flori N, Guibert P, Piessen G, Farges-Bancel D, Seitz JF, Assenat E, Vendrely V, Truant S, Vanbiervliet G, Berthelémy P, Garcia S, et al. A prospective clinical and biological database for pancreatic adenocarcinoma: the BACAP cohort. Bmc Cancer. 18: 986. PMID 30326968 DOI: 10.1186/S12885-018-4906-4  0.338
2018 Renaud F, Chetboun M, Thevenet J, Delalleau N, Gmyr V, Hubert T, Bonner C, Messager M, Leteurtre E, Mariette C, Kerr-Conte J, Piessen G, Pattou F. Safety of Islet Autotransplantation Following Pancreatectomy for Adenocarcinoma. Transplantation. PMID 30113997 DOI: 10.1097/Tp.0000000000002419  0.319
2018 Baiocchi GL, Giacopuzzi S, Marrelli D, Reim D, Piessen G, Matos da Costa P, Reynolds JV, Meyer HJ, Morgagni P, Gockel I, Lara Santos L, Jensen LS, Murphy T, Preston SR, Ter-Ovanesov M, et al. International consensus on a complications list after gastrectomy for cancer. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 29846827 DOI: 10.1007/S10120-018-0839-5  0.33
2018 Vergouwe FW, Gottrand M, Wijnhoven BP, IJsselstijn H, Piessen G, Bruno MJ, Wijnen RM, Spaander MC. Four cancer cases after esophageal atresia repair: Time to start screening the upper gastrointestinal tract. World Journal of Gastroenterology. 24: 1056-1062. PMID 29531469 DOI: 10.3748/Wjg.V24.I9.1056  0.357
2018 Mege D, Depypere L, Piessen G, Slaman AE, Wijnhoven BPL, Hölscher A, Nilsson M, van Berge Henegouwen MI, van Lanschot JJB, Schroeder W, Thomas PA, Nafteux P, D'Journo XB. Surgical management of esophageal sarcoma: a multicenter European experience. Diseases of the Esophagus : Official Journal of the International Society For Diseases of the Esophagus. PMID 29444281 DOI: 10.1093/Dote/Dox146  0.345
2018 Cohen C, Tessier W, Gronnier C, Renaud F, Pasquer A, Théreaux J, Gagnière J, Meunier B, Collet D, Piessen G, Mariette C. Salvage Surgery for Esophageal Cancer: How to Improve Outcomes? Annals of Surgical Oncology. PMID 29417405 DOI: 10.1245/S10434-018-6365-1  0.375
2018 Mariette C, Renaud F, Piessen G, Gele P, Copin MC, Leteurtre E, Delaeter C, Dib M, Clisant S, Harter V, Bonnetain F, Duhamel A, Christophe V, Adenis A. The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers. Bmc Cancer. 18: 139. PMID 29409462 DOI: 10.1186/S12885-018-3991-8  0.399
2018 Bonnot PE, Piessen G, Pocard M, Meunier B, Bereder JM, Abboud K, Marchal F, Quenet F, Goere D, Msika S, Arvieux C, Pirro N, Wernert R, Rat P, Pezet D, et al. CYTO-CHIP: Cytoreductive surgery versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis: A propensity-score analysis from BIG RENAPE and FREGAT working groups. Journal of Clinical Oncology. 36: 8-8. DOI: 10.1200/Jco.2018.36.4_Suppl.8  0.383
2018 Bonnot PE, Piessen G, Mercier F, Pocard M, Meunier B, Bereder JM, Abboud K, Marchal F, Quenet F, Goere D, Arvieux C, Msika S, Pezet D, Pirro N, Wernert R, et al. Is cytoreductive surgery and hyperthermic intraperitonealchemotherapy reasonable treatment for gastric signet-ring cell adenocarcinoma and linitis plastica with peritoneal metastasis? CYTO-CHIP study—Ancillary results. Journal of Clinical Oncology. 36: 4073-4073. DOI: 10.1200/Jco.2018.36.15_Suppl.4073  0.347
2018 Mantziari S, Allemann P, Winiker M, Messier M, Demartines N, Piessen G, Schäfer M. RA05.08: OPTIMAL RADIATION DOSE IN THE NEOADJUVANT TREATMENT OF ESOPHAGEAL CANCER: A COMPARATIVE EUROPEAN STUDY Diseases of the Esophagus. 31: 29-29. DOI: 10.1093/Dote/Doy089.Ra05.08  0.326
2018 Allemann P, Mantziari S, Winiker M, Wagner AD, Digklia A, Henegouwen MvB, Gisbertz SS, Slaman A, Hillegersberg Rv, Ruurda JP, Brenkman H, Nilsson M, Satoshi K, Piessen G, Collet D, et al. Neoadjuvant radio-chemotherapy for esophageal cancer: A multicenter European study comparing paclitaxel/carboplatin, 5FU/cisplatin and FOLFOX. Annals of Oncology. 29. DOI: 10.1093/Annonc/Mdy282.014  0.363
2017 Adenis A, Piessen G, Azria D. Definitive chemoradiation for resectable carcinoma of the cervical esophagus: do we need more evidence? Annals of Translational Medicine. 5: 503. PMID 29299464 DOI: 10.21037/Atm.2017.10.27  0.379
2017 Renaud F, Bibeau F, Leteurtre E, Delaeter C, Dib M, Harter V, Adenis A, Piessen G, Mariette C. [FREGAT: French clinico-biological database dedicated to esogastric cancers]. Annales De Pathologie. 37: 457-466. PMID 29196094 DOI: 10.1016/J.Annpat.2017.10.005  0.326
2017 Lahdaoui F, Messager M, Vincent A, Hec F, Gandon A, Warlaumont M, Renaud F, Leteurtre E, Piessen G, Jonckheere N, Mariette C, Van Seuningen I. Depletion of MUC5B mucin in gastrointestinal cancer cells alters their tumorigenic properties: Implication of the Wnt/β-catenin pathway. The Biochemical Journal. PMID 28972071 DOI: 10.1042/Bcj20170348  0.745
2017 Degisors S, Pasquer A, Renaud F, Béhal H, Hec F, Gandon A, Vanderbeken M, Caranhac G, Duhamel A, Piessen G, Mariette C. Are Thoracotomy and/or Intrathoracic Anastomosis Still Predictors of Postoperative Mortality After Esophageal Cancer Surgery?: A Nationwide Study. Annals of Surgery. PMID 28742697 DOI: 10.1097/Sla.0000000000002401  0.325
2017 Mariette C, Brouquet A, Tzanis D, Laurenzi A, Rochefordière Adl, Mariani P, Piessen G, Cunha AS, Penna C. What is the impact of neoadjuvant chemoradiation on outcomes in gastro-intestinal cancer? Journal of Visceral Surgery. 154: 185-195. PMID 28602545 DOI: 10.1016/J.Jviscsurg.2017.05.004  0.359
2017 Desbeaux A, Gronnier C, Piessen G, Vanderbeken M, Ruolt N, Triboulet JP, Mariette C. Same-day discharge in benign esophageal surgery: a prospective cohort study. Diseases of the Esophagus : Official Journal of the International Society For Diseases of the Esophagus. 30: 1-7. PMID 28375480 DOI: 10.1093/Dote/Dow036  0.305
2017 Mariette C, Pasquer A, Renaud F, Hec F, Gandon A, Vanderbeken M, Degisors S, Caranhac G, Piessen G. Postoperative mortality after esophageal and gastric cancer surgery: Does age still matter? Results from a nationwide study. Journal of Clinical Oncology. 35: 122-122. DOI: 10.1200/Jco.2017.35.4_Suppl.122  0.354
2017 Mariette C, Markar S, Dabakuyo-Yonli TS, Meunier B, Pezet D, Collet D, D'Journo XB, Brigand C, Perniceni T, Carrere N, Bonnetain F, Piessen G. 615O_PRHybrid minimally invasive vs. open esophagectomy for patients with esophageal cancer: Long-term outcomes of a multicenter, open-label, randomized phase III controlled trial, the MIRO trial Annals of Oncology. 28. DOI: 10.1093/Annonc/Mdx440.023  0.304
2016 Lefevre JH, Mineur L, Kotti S, Rullier E, Rouanet P, de Chaisemartin C, Meunier B, Mehrdad J, Cotte E, Desrame J, Karoui M, Benoist S, Kirzin S, Berger A, Panis Y, ... Piessen G, et al. Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27432930 DOI: 10.1200/Jco.2016.67.6049  0.357
2016 Pasquer A, Renaud F, Hec F, Gandon A, Vanderbeken M, Drubay V, Caranhac G, Piessen G, Mariette C. Is Centralization Needed for Esophageal and Gastric Cancer Patients With Low Operative Risk?: A Nationwide Study. Annals of Surgery. PMID 27429033 DOI: 10.1097/Sla.0000000000001768  0.357
2016 Gandon A, Gronnier C, Renaud F, Borde P, Vanderbeken M, Hec F, Piessen G, Adenis A, Mirabel X, Mariette C. Esophageal Adenocarcinoma: Impact of a Large Hiatal Hernia on Outcomes After Surgery. Annals of Surgery. PMID 27429032 DOI: 10.1093/Annonc/Mdw371.49  0.332
2016 Messager M, Warlaumont M, Renaud F, Marin H, Branche J, Piessen G, Mariette C. Recent improvements in the management of esophageal anastomotic leak after surgery for cancer. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. PMID 27396305 DOI: 10.1016/J.Ejso.2016.06.394  0.327
2016 Meghelli L, Narducci F, Mariette C, Piessen G, Vanseymortier M, Leblanc E, Collinet P, Duhamel A, Penel N. Reporting adverse events in cancer surgery randomized trials: A systematic review of published trials in oesophago-gastric and gynecological cancer patients. Critical Reviews in Oncology/Hematology. PMID 27323658 DOI: 10.1016/J.Critrevonc.2016.05.017  0.352
2016 Messager M, Mirabel X, Tresch E, Paumier A, Vendrely V, Dahan L, Glehen O, Vasseur F, Lacornerie T, Piessen G, El Hajbi F, Robb WB, Clisant S, Kramar A, Mariette C, et al. Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial. Bmc Cancer. 16: 318. PMID 27194176 DOI: 10.1186/S12885-016-2335-9  0.38
2016 Gronnier C, Piessen G, Mariette C. Laparoscopic gastric mobilization and lymphadenectomy during Ivor Lewis esophagectomy. Journal of Visceral Surgery. 153: 203-8. PMID 27032315 DOI: 10.1016/J.Jviscsurg.2016.03.002  0.312
2016 Crombe T, Bot J, Messager M, Roger V, Mariette C, Piessen G. Malignancy is a risk factor for postoperative infectious complications after elective colorectal resection. International Journal of Colorectal Disease. 31: 885-94. PMID 26838016 DOI: 10.1007/S00384-016-2521-X  0.337
2016 Kotecki N, Hiret S, Etienne PL, Penel N, Tresch E, François E, Galais MP, Ben Abdelghani M, Michel P, Dahan L, Ghiringelli F, Bedenne L, Samalin E, Piessen G, Bennouna J, et al. First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease Control. Oncology. 90: 88-96. PMID 26784946 DOI: 10.1159/000442947  0.346
2016 Gronnier C, Pasquer A, Renaud F, Hec F, Gandon A, Vanderbeken M, Drubay V, Caranhac G, Piessen G, Mariette C. Is centralization needed for esophago-gastric cancer patients with low operative risk? a nationwide study Annals of Oncology. 27: vi207. DOI: 10.1093/Annonc/Mdw371.01  0.352
2016 Bennouna J, Etienne P, Bogart E, Galais M, Benabdelghani M, Francois E, Michel P, Dahan L, Metges J, Ghiringhelli F, Conroy T, Kotecki N, Bedenne L, El Hajbi F, Samalin E, ... Piessen G, et al. LBA-04The E-DIS study, a randomized discontinuation trial of first-line chemotherapy (CT) in patients with metastatic squamous-cell esophageal cancer (MSEC): efficacy and quality of life results Annals of Oncology. 27: ii141-ii141. DOI: 10.1093/Annonc/Mdw237.4  0.325
2016 Gronnier C, Piessen G, Mariette C. Temps abdominal laparoscopique de l’intervention d’œsophagectomie pour cancer selon Lewis-Santy Journal De Chirurgie ViscéRale. 153: 210-215. DOI: 10.1016/J.Jchirv.2016.03.002  0.34
2015 Piessen G, Lefèvre JH, Cabau M, Duhamel A, Behal H, Perniceni T, Mabrut JY, Regimbeau JM, Bonvalot S, Tiberio GA, Mathonnet M, Regenet N, Guillaud A, Glehen O, Mariani P, et al. Laparoscopic Versus Open Surgery for Gastric Gastrointestinal Stromal Tumors: What Is the Impact on Postoperative Outcome and Oncologic Results? Annals of Surgery. 262: 831-40. PMID 26583673 DOI: 10.1097/Sla.0000000000001488  0.37
2015 Messager M, Pasquer A, Duhamel A, Caranhac G, Piessen G, Mariette C. Laparoscopic Gastric Mobilization Reduces Postoperative Mortality After Esophageal Cancer Surgery: A French Nationwide Study. Annals of Surgery. 262: 817-22; discussion 8. PMID 26583671 DOI: 10.1097/Sla.0000000000001470  0.371
2015 Mariette C, Robb WB, Piessen G, Adenis A. Neoadjuvant chemoradiation in oesophageal cancer. The Lancet. Oncology. 16: 1008-9. PMID 26254684 DOI: 10.1016/S1470-2045(15)00127-8  0.347
2015 Gronnier C, Bekkar S, Messager M, Piessen G, Mariette C. Is There a Role for Preoperative Chemoradiation in Esophageal Signet Ring Cell Adenocarcinomas? The Annals of Thoracic Surgery. 99: 2253-4. PMID 26046895 DOI: 10.1016/J.Athoracsur.2014.11.031  0.311
2015 Robb WB, Messager M, Gronnier C, Tessier W, Hec F, Piessen G, Mariette C. High-Grade Toxicity to Neoadjuvant Treatment for Upper Gastrointestinal Carcinomas: What is the Impact on Perioperative and Oncologic Outcomes? Annals of Surgical Oncology. 22: 3632-9. PMID 25676845 DOI: 10.1245/S10434-015-4423-5  0.393
2015 Mariette C, Gronnier C, Duhamel A, Mabrut JY, Bail JP, Carrere N, Lefevre JH, Meunier B, Collet D, Piessen G. Self-expanding covered metallic stent as a bridge to surgery in esophageal cancer: impact on oncologic outcomes. Journal of the American College of Surgeons. 220: 287-96. PMID 25617915 DOI: 10.1016/J.Jamcollsurg.2014.11.028  0.331
2015 Robb WB, Bruyere E, Amielh D, Vinatier E, Mabrut JY, Perniceni T, Piessen G, Mariette C. Esophageal gastrointestinal stromal tumor: is tumoral enucleation a viable therapeutic option? Annals of Surgery. 261: 117-24. PMID 25062398 DOI: 10.1097/Sla.0000000000000505  0.758
2015 Mariette C, Robb WB, Piessen G. Reply to Letter: "The Role of Surgery for Patients With a Complete Clinical Response After Chemoradiation for Esophageal Cancer". Annals of Surgery. 262: e101-2. PMID 24670853 DOI: 10.1097/Sla.0000000000000668  0.36
2015 Gronnier C, Piessen G, Leteurtre E, Van Seuningen I, Mariette C. Suitability of surgically induced chronic reflux in rats for studying esophageal carcinogenesis. Annals of Surgery. 261: e140-1. PMID 24374550 DOI: 10.1097/Sla.0000000000000474  0.592
2015 Mariette C, Meunier B, Pezet D, Dalban C, Collet D, Thomas P, Brigand C, Perniceni T, Carrere N, Bonnetain F, Piessen G. Hybrid minimally invasive versus open oesophagectomy for patients with oesophageal cancer: A multicenter, open-label, randomized phase III controlled trial, the MIRO trial. Journal of Clinical Oncology. 33: 5-5. DOI: 10.1200/Jco.2015.33.3_Suppl.5  0.382
2015 Mariette C, Piessen G, Monterymard C, Pezet D, Ferru A, Baconnier M, Adhoute X, Tavan D, Bouche O. Efficacy and safety of perioperative chemotherapy with 5FU-cisplatine-cetuximab in gastric and gastroesophageal junction adenocarcinomas (GGOJA): A single-arm multicenter phase II trial (FFCD 0901). Journal of Clinical Oncology. 33: 154-154. DOI: 10.1200/Jco.2015.33.3_Suppl.154  0.331
2015 Leila M, Narducci F, Mariette C, Alain D, Vanseymortier M, Leblanc E, Paoletti X, Collinet P, Clisant S, Piessen G, Penel N. 901 Reporting adverse events (AEs) in cancer surgery randomized trial: A systemic analysis of published trials in oesogastric (OG) and gynecological (GY) cancer patients European Journal of Cancer. 51: S140. DOI: 10.1016/S0959-8049(16)30409-9  0.334
2014 Gronnier C, Tréchot B, Duhamel A, Mabrut JY, Bail JP, Carrere N, Lefevre JH, Brigand C, Vaillant JC, Adham M, Msika S, Demartines N, El Nakadi I, Piessen G, Meunier B, et al. Impact of neoadjuvant chemoradiotherapy on postoperative outcomes after esophageal cancer resection: results of a European multicenter study. Annals of Surgery. 260: 764-70; discussion 7. PMID 25379847 DOI: 10.1097/Sla.0000000000000955  0.379
2014 Piessen G, Messager M, Lefevre JH, Goéré D, Mabrut JY, Meunier B, Brigand C, Hamy A, Glehen O, Mariette C. Signet ring cell adenocarcinomas: different clinical-pathological characteristics of oesophageal and gastric locations. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 40: 1746-55. PMID 25012732 DOI: 10.1016/J.Ejso.2014.04.019  0.348
2014 Gronnier C, Bruyère E, Lahdaoui F, Jonckheere N, Perrais M, Leteurtre E, Piessen G, Mariette C, Van Seuningen I. The MUC1 mucin regulates the tumorigenic properties of human esophageal adenocarcinomatous cells. Biochimica Et Biophysica Acta. 1843: 2432-7. PMID 25003315 DOI: 10.1016/J.Bbamcr.2014.06.021  0.721
2014 Tessier W, Gronnier C, Messager M, Hec F, Mirabel X, Robb WB, Piessen G, Mariette C. Does timing of surgical procedure after neoadjuvant chemoradiation affect outcomes in esophageal cancer? The Annals of Thoracic Surgery. 97: 1181-9. PMID 24529482 DOI: 10.1016/J.Athoracsur.2013.12.026  0.391
2014 Bekkar S, Gronnier C, Messager M, Robb WB, Piessen G, Mariette C. The impact of preoperative radiochemotherapy on survival in advanced esophagogastric junction signet ring cell adenocarcinoma. The Annals of Thoracic Surgery. 97: 303-10. PMID 24200394 DOI: 10.1016/J.Athoracsur.2013.09.010  0.385
2013 Piessen G, Messager M, Mirabel X, Briez N, Robb WB, Adenis A, Mariette C. Is there a role for surgery for patients with a complete clinical response after chemoradiation for esophageal cancer? An intention-to-treat case-control study. Annals of Surgery. 258: 793-9; discussion 79. PMID 24096755 DOI: 10.1097/Sla.0000000000000228  0.387
2013 Gronnier C, Bruyère E, Piessen G, Briez N, Bot J, Buob D, Leteurtre E, Van Seuningen I, Mariette C. Operatively induced chronic reflux in rats: a suitable model for studying esophageal carcinogenesis? Surgery. 154: 955-67. PMID 24084597 DOI: 10.1016/J.Surg.2013.05.029  0.736
2013 Gronnier C, Messager M, Robb WB, Thiebot T, Louis D, Luc G, Piessen G, Mariette C. Is the negative prognostic impact of signet ring cell histology maintained in early gastric adenocarcinoma? Surgery. 154: 1093-9. PMID 24075273 DOI: 10.1016/J.Surg.2013.05.020  0.32
2013 Mariette C, Briez N, Denies F, Dervaux B, Duhamel A, Guilbert M, Bruyère E, Robb WB, Piessen G. Use of biological mesh versus standard wound care in infected incisional ventral hernias, the SIMBIOSE study: a study protocol for a randomized multicenter controlled trial. Trials. 14: 131. PMID 23782773 DOI: 10.1186/1745-6215-14-131  0.732
2013 Piessen G, Messager M, Le Malicot K, Robb WB, Di Fiore F, Guilbert M, Moreau M, Christophe V, Adenis A, Mariette C. Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas - PRODIGE 19 - FFCD1103 - ADCI002. Bmc Cancer. 13: 281. PMID 23758655 DOI: 10.1186/1471-2407-13-281  0.368
2013 Canon B, Collinet P, Piessen G, Rubod C. [Segmentary rectal resection and rectal shaving by laparoscopy for endometriosis: peri-operative morbidity]. GynéCologie, ObstéTrique & Fertilité. 41: 275-81. PMID 23660479 DOI: 10.1016/J.Gyobfe.2013.02.005  0.32
2013 Piessen G, Messager M, Robb WB, Bonnetain F, Mariette C. Gastric signet ring cell carcinoma: how to investigate its impact on survival. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2059-60. PMID 23610107 DOI: 10.1200/Jco.2012.47.4338  0.333
2013 Bot J, Piessen G, Robb WB, Roger V, Mariette C. Advanced tumor stage is an independent risk factor of postoperative infectious complications after colorectal surgery: arguments from a case-matched series. Diseases of the Colon and Rectum. 56: 568-76. PMID 23575395 DOI: 10.1097/Dcr.0B013E318282E790  0.375
2013 Piessen G, Petyt G, Duhamel A, Mirabel X, Huglo D, Mariette C. Ineffectiveness of ¹⁸F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer. Annals of Surgery. 258: 66-76. PMID 23470576 DOI: 10.1097/Sla.0B013E31828676C4  0.329
2013 Honoré C, Goéré D, Messager M, Souadka A, Dumont F, Piessen G, Elias D, Mariette C. Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: results of a multicentre retrospective study. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 39: 235-41. PMID 23313257 DOI: 10.1016/J.Ejso.2012.12.013  0.363
2013 Mariette C, Bruyère E, Messager M, Pichot-Delahaye V, Paye F, Dumont F, Brachet D, Piessen G. Palliative resection for advanced gastric and junctional adenocarcinoma: which patients will benefit from surgery? Annals of Surgical Oncology. 20: 1240-9. PMID 23064779 DOI: 10.1245/S10434-012-2687-6  0.774
2013 Tessier W, Piessen G, Briez N, Boschetto A, Sergent G, Mariette C. Percutaneous radiological gastrostomy in esophageal cancer patients: a feasible and safe access for nutritional support during multimodal therapy. Surgical Endoscopy. 27: 633-41. PMID 22956002 DOI: 10.1007/S00464-012-2506-Y  0.405
2012 Briez N, Piessen G, Torres F, Lebuffe G, Triboulet JP, Mariette C. Effects of hybrid minimally invasive oesophagectomy on major postoperative pulmonary complications. The British Journal of Surgery. 99: 1547-53. PMID 23027071 DOI: 10.1002/Bjs.8931  0.333
2012 Gronnier C, Piessen G, Mariette C. Diagnosis and treatment of non-metastatic esophagogastric junction adenocarcinoma: what are the current options? Journal of Visceral Surgery. 149: e23-33. PMID 22341763 DOI: 10.1016/J.Jviscsurg.2012.01.003  0.364
2012 Mariette C, De Botton ML, Piessen G. Surgery in esophageal and gastric cancer patients: what is the role for nutrition support in your daily practice? Annals of Surgical Oncology. 19: 2128-34. PMID 22322948 DOI: 10.1245/S10434-012-2225-6  0.363
2012 Mariette C, Piessen G. Oesophageal cancer: how radical should surgery be? European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 38: 210-3. PMID 22236956 DOI: 10.1016/J.Ejso.2011.12.022  0.355
2012 Piessen G, Amielh D, Messager M, Vinatier E, Leteurtre E, Triboulet JP, Mariette C. Is pretreatment endoscopic biopsy a good predictor of signet ring cell histology in gastric carcinoma? World Journal of Surgery. 36: 346-54. PMID 22102091 DOI: 10.1007/S00268-011-1351-9  0.382
2012 Robb W, Bruyère E, Messager M, Pichot-Delahaye V, Paye F, Dumont F, Brachet D, Piessen G, Mariette C. 89. Palliative resection for advanced gastric and junctional adenocarcinoma: Which patients will benefit from surgery? – On Behalf of the FREGat Working Group - FRENCH European Journal of Surgical Oncology. 38: 760. DOI: 10.1016/J.Ejso.2012.06.089  0.358
2011 Mariette C, Messager M, Lefevre JH, Pichot V, Souadka A, Thibot T, Brachet D, Carrere N, Fernandez M, Guiramand J, Tsilividis B, Flamein R, Kraft K, Balon JM, Borie F, ... ... Piessen G, et al. Effect of neoadjuvant chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: A multicentric comparative study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4036. PMID 28020530 DOI: 10.1200/Jco.2011.29.15_Suppl.4036  0.354
2011 Messager M, Lefevre JH, Pichot-Delahaye V, Souadka A, Piessen G, Mariette C. The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study. Annals of Surgery. 254: 684-93; discussion 6. PMID 22005144 DOI: 10.1097/Sla.0B013E3182352647  0.357
2011 Briez N, Piessen G, Bonnetain F, Brigand C, Carrere N, Collet D, Doddoli C, Flamein R, Mabrut JY, Meunier B, Msika S, Perniceni T, Peschaud F, Prudhomme M, Triboulet JP, et al. Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial. Bmc Cancer. 11: 310. PMID 21781337 DOI: 10.1186/1471-2407-11-310  0.371
2011 Mariette C, Piessen G, Briez N, Gronnier C, Triboulet JP. Oesophagogastric junction adenocarcinoma: which therapeutic approach? The Lancet. Oncology. 12: 296-305. PMID 21109491 DOI: 10.1016/S1470-2045(10)70125-X  0.385
2010 Piessen G, Wacrenier A, Briez N, Triboulet JP, Van Seuningen I, Mariette C. Clinical impact of MUC1 and MUC4 expression in Barrett-associated oesophageal adenocarcinoma. Journal of Clinical Pathology. 62: 1144-6. PMID 19946103 DOI: 10.1136/Jcp.2008.060780  0.59
2010 Messager M, Millet G, Briez N, Piessen G, Triboulet J, Mariette C. Survival of complete responder patients treated for esophageal cancer with chemoradiotherapy followed by surgery as compared to chemoradiotherapy alone: Case-control study. Journal of Clinical Oncology. 28: 4089-4089. DOI: 10.1200/Jco.2010.28.15_Suppl.4089  0.384
2010 Briez N, Piessen G, Claret A, Triboulet J, Mariette C. Is minimally invasive œsophagectomy for cancer decreasing pulmonary complications? Results from a case-control study. Journal of Clinical Oncology. 28: 4071-4071. DOI: 10.1200/Jco.2010.28.15_Suppl.4071  0.344
2009 Piessen G, Messager M, Leteurtre E, Jean-Pierre T, Mariette C. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Annals of Surgery. 250: 878-87. PMID 19855261 DOI: 10.1097/Sla.0B013E3181B21C7B  0.363
2009 Mariette C, Messager M, Millet G, Briez N, Piessen G, Triboulet J. 6540 Survival of complete responder patients treated for oesophageal cancer is better after chemoradiotherapy followed by surgery than chemioradiotherapy alone – Case control study European Journal of Cancer Supplements. 7: 373. DOI: 10.1016/S1359-6349(09)71262-5  0.364
2009 Mariette C, Briez N, Piessen G, Claret A, Triboulet J. 6538 Is minimally invasive œsophagectomy for cancer decreasing pulmonary complications? – results from a case-control study European Journal of Cancer Supplements. 7: 373. DOI: 10.1016/S1359-6349(09)71260-1  0.318
2009 Bruyère E, Briez N, Piessen G, Buob D, Leteurtre E, Mariette C, VAN SEUNINGEN I. T1940 Molecular Characterization of An Animal Model of Oesophageal Carcinogenesis Induced By Gastro-Oesophageal Reflux in Rats: Identification of New Potential Biomarkers Gastroenterology. 136: A-605. DOI: 10.1016/S0016-5085(09)62787-6  0.738
2008 Mariette C, Piessen G, Leteurtre E, Hémon B, Triboulet JP, Van Seuningen I. Activation of MUC1 mucin expression by bile acids in human esophageal adenocarcinomatous cells and tissues is mediated by the phosphatidylinositol 3-kinase. Surgery. 143: 58-71. PMID 18154934 DOI: 10.1016/J.Surg.2007.07.043  0.619
2008 Piessen G, Lamblin A, Triboulet JP, Mariette C. Peptic ulcer of the gastric tube after esophagectomy for cancer: clinical implications. Diseases of the Esophagus : Official Journal of the International Society For Diseases of the Esophagus. 20: 542-5. PMID 17958733 DOI: 10.1111/J.1442-2050.2007.00706.X  0.382
2007 Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. The Lancet. Oncology. 8: 545-53. PMID 17540306 DOI: 10.1016/S1470-2045(07)70172-9  0.365
2007 Piessen G, Briez N, Triboulet JP, Mariette C. Patients with locally advanced esophageal carcinoma nonresponder to radiochemotherapy: who will benefit from surgery? Annals of Surgical Oncology. 14: 2036-44. PMID 17453293 DOI: 10.1245/S10434-007-9405-9  0.346
2007 Piessen G, Jonckheere N, Vincent A, Hémon B, Ducourouble MP, Copin MC, Mariette C, Van Seuningen I. Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1alpha. The Biochemical Journal. 402: 81-91. PMID 17037983 DOI: 10.1042/Bj20061461  0.751
2006 Mariette C, Piessen G, Lamblin A, Mirabel X, Adenis A, Triboulet JP. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma. The British Journal of Surgery. 93: 1077-83. PMID 16779882 DOI: 10.1002/Bjs.5358  0.357
2006 Leteurtre E, Zerimech F, Piessen G, Wacrenier A, Leroy X, Copin MC, Mariette C, Aubert JP, Porchet N, Buisine MP. Relationships between mucinous gastric carcinoma, MUC2 expression and survival. World Journal of Gastroenterology. 12: 3324-31. PMID 16733847 DOI: 10.3748/Wjg.V12.I21.3324  0.35
2005 Mariette C, Finzi L, Piessen G, Van Seuningen I, Triboulet JP. Esophageal carcinoma: Prognostic differences between squamous cell carcinoma and adenocarcinoma World Journal of Surgery. 29: 39-45. PMID 15599738 DOI: 10.1007/S00268-004-7542-X  0.63
2005 Mariette C, Piessen G, Balon JM, Van Seuningen I, Triboulet JP. Surgery alone in the curative treatment of localised oesophageal carcinoma. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 30: 869-76. PMID 15336734 DOI: 10.1016/J.Ejso.2004.06.009  0.592
Show low-probability matches.